维生素D补充预防2型糖尿病:补还是不补?
本文综述了观察性研究和临床试验证据,探讨维生素D补充对糖尿病前期人群2型糖尿病发病风险的影响。纵向观察性研究显示较高的血25-羟维生素D水平与较低的糖尿病发病风险相关;在3项专门设计用于糖尿病预防的大型试验中,与安慰剂相比,维生素D补充使未根据维生素D缺乏挑选的糖尿病前期人群的糖尿病发病风险降低10%至13%。
要点
- 纵向观察性研究一致显示较高的血25(OH)D水平与较低的糖尿病发病风险相关。
- 在糖尿病前期人群中,维生素D补充试验显示糖尿病发病风险降低。
- 3项大型预防试验中,与安慰剂相比,维生素D补充使未根据维生素D缺乏挑选的糖尿病前期人群发病风险降低10%至13%。
核心结论
- 近期试验结果与大量观察性研究证据一致,表明维生素D在调节糖尿病风险中发挥作用。
- 对3项最大试验的参与者水平Meta分析应能提供更精确的风险降低估计,并识别最可能从维生素D补充中获益的患者人群。
研究设计与样本
- 通过PubMed、Embase和ClinicalTrials.gov进行综合文献综述,纳入近期关于血25(OH)D水平与糖尿病发病关联的纵向观察性研究的Meta分析,以及报告维生素D补充对糖尿病发病影响的成人糖尿病前期临床试验。
主要发现
- 纵向观察性研究显示,在不同人群中(包括糖尿病前期人群),较高的血25(OH)D水平与较低的糖尿病发病风险高度一致地相关。
- 在糖尿病前期人群中,维生素D补充试验显示糖尿病发病风险降低。
- 在3项专门设计并实施用于糖尿病预防的大型试验中,与安慰剂相比,维生素D补充使未根据维生素D缺乏挑选的糖尿病前期人群的糖尿病发病风险降低10%至13%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Over the last decade, vitamin D has emerged as a risk determinant for type 2 diabetes and vitamin D supplementation has been hypothesized as a potential intervention to lower diabetes risk. Recently, several trials have reported on the effect of vitamin D supplementation on diabetes prevention in people with prediabetes. EVIDENCE ACQUISITION: A comprehensive literature review was performed using PubMed, Embase, and ClinicalTrials.gov to identify: (1) recent meta-analyses of longitudinal observational studies that report on the association between blood 25-hydroxyvitamin D (25[OH]D) level and incident diabetes, and (2) clinical trials of adults with prediabetes that have reported on the effect of vitamin D supplementation on incident diabetes. EVIDENCE SYNTHESIS: Longitudinal observational studies report highly consistent associations between higher blood 25(OH)D levels and a lower risk of incident diabetes in diverse populations, including populations with prediabetes. Trials in persons with prediabetes show risk reduction in incident diabetes with vitamin D supplementation. In the 3 large trials that were specifically designed and conducted for the prevention of diabetes, vitamin D supplementation, when compared with placebo, reduced the risk of developing diabetes by 10% to 13% in persons with prediabetes not selected for vitamin D deficiency. CONCLUSIONS: Results from recent trials are congruent with a large body of evidence from observational studies indicating that vitamin D has a role in modulating diabetes risk. Participant-level meta-analysis of the 3 largest trials should provide a more refined estimate of risk reduction and identify patient populations that are likely to benefit the most from vitamin D supplementation.
引用
- Pittas AG, Jorde R, Kawahara T, et al. Vitamin D Supplementation for Prevention of Type 2 Diabetes Mellitus: To D or Not to D? J Clin Endocrinol Metab. 2020. PMID: 32844212. doi:10.1210/clinem/dgaa594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。